Dr. Nagender Sharma

Principal Consultant

17 Years of Experience

Medical Oncologist

MBBS, MD, DM, DNB

Reg. No.:37075, Delhi Medical Council

English, Hindi

Consultation Fee ₹ 600

Book an Appointment Contact with Doctor

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Dr. Nagender Sharma is a leading Medical Oncologist in Gurgaon.
He has over 17 years of extensive experience.
His areas of expertise include diagnosing and managing cancer of the breast, gastrointestinal tract, thoracic, head and neck, genitourinary tract, and gynecology.
He is also well-versed in treating sarcomas and rare cancers.
Dr. Sharma offers cancer immunotherapy, hormone therapy, targeted therapy, and cancer vaccination.
He completed his MBBS from Kasturba Medical College, Mangalore, in 2007 and his MD in General Medicine from Mahadeva Rampure Medical College, Gulbarga, in 2011.
Later, he specialized in managing cancer patients, earning a DM in Oncology from Adyar Cancer Institute, Chennai, in 2017 and a DNB in Medical Oncology from the National Board of Examination, New Delhi.
Dr. Sharma also holds the European Society of Medical Oncology Certification (ESMO).
He is an avid researcher with multiple publications in reputed cancer journals.
He holds memberships in prestigious medical societies and associations, such as the Indian Society of Medical and Paediatric Oncology, the American Society of Clinical Oncology, and the European Society for Medical Oncology.

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Consultant (Medical Oncology & Hematology), Medanta The Medicity, Gurugram, 2022

TALAPRO-3, A Phase III Randomised, Double-Blind, Study of Talazoparib with Enzalutamide Versus Placebo with Enzalutamide in Men with DDR Gene Mutated Metastatic Castration Sensitive Prostate Cancer
Paralysis of Diaphragm after SBRT of Lung Cancer (J Radiosurgery)
Subclinical Hyperthyroidism in post-Immunotherapy Lung Cancer on FFDG PET/CT-An Incidental Observation (IJC)
Ecacy and Safety of Palbociclib in Treatment of HR-positive Advanced Breast Cancer Patients: A Single Center Real-world Experience (JCO)
Survival Outcomes in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Evidence Study from India (JCO)